Company Filing History:
2 out of 3,559 
2 out of 213 
1 out of 11 Years Active: 2007-2013
Title: Gerard Deleris: Innovator in Cyclic Peptides
Introduction
Gerard Deleris is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of cyclic peptides, particularly in their application as angiogenesis inhibitors or activators. With a total of 2 patents, Deleris has established himself as a key figure in this area of research.
Latest Patents
Deleris's latest patents focus on cyclic peptides and their methods of preparation. One of his inventions relates to the use of these cyclopeptides as inhibitors or activators of angiogenesis. The specific peptide sequence he has worked with includes Arg-Ile-Lys-Pro-His-Gln-Gly. These cyclopeptides can be utilized in systems designed to inhibit angiogenesis, where they are affixed to a support via an organic spacer arm that may contain a moiety capable of being cleaved by an enzyme system.
Career Highlights
Throughout his career, Gerard Deleris has worked with prominent organizations such as the Commissariat à l'Énergie Atomique and the Université de Bordeaux. His work has been instrumental in advancing the understanding and application of cyclic peptides in medical research.
Collaborations
Deleris has collaborated with notable colleagues, including Natacha Betz and Andreas Bikfalvi. These partnerships have contributed to the development and refinement of his innovative ideas in the field of cyclic peptides.
Conclusion
Gerard Deleris is a distinguished inventor whose work in cyclic peptides has the potential to impact medical science significantly. His patents and collaborations reflect his commitment to advancing research in angiogenesis.